INSULET CORP
Nasdaq · Surgical & Medical Instruments & Apparatus
Company Overview
A concise company profile alongside the latest public filing activity.
Insulet Corporation makes the Omnipod, a tubeless, wearable insulin delivery system for people with diabetes that adheres to the skin and is controlled via a handheld device or smartphone app, eliminating the need for traditional insulin injections or tubed pumps.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| McEvoy AshleyPresident and CEO | Buy | $162K | 1,100at $147.47 | Aug 21, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
| Member | Chamber | Type | Amount | Date |
|---|---|---|---|---|
| Gilbert CisnerosCA31 | House | Buy | $1,001 - $15,000 | Aug 18, 2026 |
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable PODD activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.